Search - tctmd.com

Displaying 761 - 780 of 870

Sort: Relevancy | Date

News Daily News

CoreValve Reduce la Mortalidad al cabo de 1 Año en Pacientes de Riesgo Quirúrgico Extremo

March 20, 2014

News Industry News

St. Jude Medical Announces Start of European Post-Approval Trial for Nanostim Leadless Pacemaker

March 18, 2014

News Industry News

Medtronic Announces First U.S. Implant of World's Smallest, Minimally Invasive Cardiac Pacemaker

February 19, 2014

News Daily News

Survival After Septal Ablation for HOCM Similar to General Population

L.A. McKeown

February 06, 2014

News Industry News

St. Jude Medical Announces First US Patient Implant of Non-Surgical, Leadless Cardiac Pacemaker

February 05, 2014

News Daily News

TAVR-Linked Conduction Abnormality Worsens Functional Status, but Not Mortality

Jason Kahn

January 16, 2014

News Daily News

La Anomalía en la Condución secundaria a la TAVR Empeora el Estado Funcional, No la Mortalidad

Jason Kahn

January 16, 2014

News Conference News TCT 2013

TAVR a Viable Option for Intermediate-Risk Patients

November 05, 2013

News Conference News TCT 2013

Second-Generation TAVR Device Overcomes Issues of Current Valves

October 31, 2013

News Conference News TCT 2013

VA Medical Centers’ CART Program Improves Patient Care, Longitudinal Research

October 30, 2013

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

Presentation TCT 2013

TCT-120. Need for Permanent Pacemaker Following Implantation of the Repositionable Second-Generation LOTUS™ Device for Transcatheter Aortic Valve Replacement: Results From the...

Presenter: Nicolas Dumonteil

October 29, 2013

Presentation TCT 2013

TCT-115. Predictors and Clinical Consequences of Permanent Pacemaker Implantation after TAVR in the PARTNER Experience

Presenter: Tamim Nazif

October 29, 2013

News Industry News

St. Jude Medical Reports Positive Clinical Outcomes from Portico Heart Valve Study

October 29, 2013

Presentation TCT 2013

New Pacemakers After TAVR: Frequency, Predictors, Clinical Outcomes, and Guidelines on "When to Treat"

Presenter: Karl-Heinz Kuck

October 28, 2013

News Industry News

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

October 28, 2013

News Daily News

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

October 25, 2013

News Industry News

FDA Advisory Panel Recommends Expanded Indication for Medtronic CRT Devices in Patients with AV Block and Reduced Heart Function

October 08, 2013

News Daily News

Transfemoral Access Not Only Option for TAVR

Yael L. Maxwell

October 04, 2013

News Daily News

Meta-analysis: Women Fare Better Than Men After TAVR Despite More Complications

Yael L. Maxwell

September 27, 2013

Advertisement

CoreValve Reduce la Mortalidad al cabo de 1 Año en Pacientes de Riesgo Quirúrgico Extremo

St. Jude Medical Announces Start of European Post-Approval Trial for Nanostim Leadless Pacemaker

Medtronic Announces First U.S. Implant of World's Smallest, Minimally Invasive Cardiac Pacemaker

Survival After Septal Ablation for HOCM Similar to General Population

St. Jude Medical Announces First US Patient Implant of Non-Surgical, Leadless Cardiac Pacemaker

TAVR-Linked Conduction Abnormality Worsens Functional Status, but Not Mortality

La Anomalía en la Condución secundaria a la TAVR Empeora el Estado Funcional, No la Mortalidad

TAVR a Viable Option for Intermediate-Risk Patients

Second-Generation TAVR Device Overcomes Issues of Current Valves

VA Medical Centers’ CART Program Improves Patient Care, Longitudinal Research

Innovation in Intervention: Perspectives from Industry

TCT-120. Need for Permanent Pacemaker Following Implantation of the Repositionable Second-Generation LOTUS™ Device for Transcatheter Aortic Valve Replacement: Results From the...

TCT-115. Predictors and Clinical Consequences of Permanent Pacemaker Implantation after TAVR in the PARTNER Experience

St. Jude Medical Reports Positive Clinical Outcomes from Portico Heart Valve Study

New Pacemakers After TAVR: Frequency, Predictors, Clinical Outcomes, and Guidelines on "When to Treat"

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

FDA Advisory Panel Recommends Expanded Indication for Medtronic CRT Devices in Patients with AV Block and Reduced Heart Function

Transfemoral Access Not Only Option for TAVR

Meta-analysis: Women Fare Better Than Men After TAVR Despite More Complications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content